Agilent Technologies vs IQVIA
Add, change or remove companies; up to four.
KIRA’s take AI analyst
I put Agilent Technologies and IQVIA side by side, using each one’s latest annual report. Here is what stands out:
- IQVIA is the larger business, with $16.3B of revenue in fiscal 2025 against $6.9B for Agilent Technologies, about 2.3 times as much.
- Agilent Technologies grew revenue faster (6.7%, against 5.9%).
- Agilent Technologies kept more of each dollar of sales as operating profit (21.3% operating margin, against 13.4%).
- Agilent Technologies turned more of its sales into free cash flow (16.6% FCF margin, against 12.6%).
- Agilent Technologies earned a higher return on the capital invested in it (16.5%, against 9.5%).
- Investors pay more for each dollar of Agilent Technologies’s earnings: a P/E of 34.7x against 33.9x for IQVIA.
Who comes out ahead
Of the 10 measures where higher (or lower) is clearly better, how many each company leads.
Agilent Technologies
A
6/10
Revenue growthOperating marginNet marginFCF marginReturn on capitalNet debt / EBITDA
IQVIA
IQV
3/10
5-year growthReturn on equityShare count change
Side by side
Best in the row
| Latest fiscal year | A FY25 | IQV FY25 |
|---|---|---|
| Size | ||
| Market cap | $49.8B | $46.5B |
| Revenue | $6.9B | $16.3B |
| Free cash flow | $1.2B | $2.1B |
| Net income | $1.3B | $1.4B |
| Growth | ||
| Revenue growth | 6.7% | 5.9% |
| 5-year growth | 5.4% | 7.5% |
| Share count change | −2.1% | −5.4% |
| Profitability | ||
| Gross margin | 52.4% | — |
| Operating margin | 21.3% | 13.4% |
| Net margin | 18.8% | 8.3% |
| FCF margin | 16.6% | 12.6% |
| Return on capital | 16.5% | 9.5% |
| Return on equity | 20.6% | 21.6% |
| Balance sheet | ||
| Net debt | $1.6B | $13.8B |
| Net debt / EBITDA | 0.9x | 4.2x |
| Dividends and buybacks | $707M | $1.2B |
| Valuation & quality | ||
| P/E | 34.7x | 33.9x |
| Piotroski F-score | 5 | 5 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.